Apollo Hospitals Enterprise Limited
₹8,265.50+₹65.50 (+0.8%)
Apollo Hospitals Enterprise Limited’s quoted price sits in the upper half of its reported 52-week range, 8.9% below the high.
NSE · MEDANTA.NS · INR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 04:14 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Global Health Limited’s quoted price sits in the upper half of its reported 52-week range, 15.71% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Global Health Limited’s forward annual dividend is ₹0.50 per share, paid annual. The forward yield is 0.04% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
BEHIND THE RESULTS
Global Health Limited’s next earnings report is currently expected on Nov 3, 2026, with estimated earnings per share of ₹6.80. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Global Health Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Operating throughout India, Global Health Limited, known by its Medanta brand, stands as a prominent multi-specialty tertiary care provider. The company delivers a comprehensive suite of healthcare services, with particular expertise in cardiology, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplantation, as well as kidney and urology treatments. Established in 2004 and headquartered in Gurgaon, India, it operates a network of four hospitals strategically located in Gurugram, Indore, Ranchi, and Lucknow.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:15 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q4 2025 | May 15, 2025 | ₹0.05-98.95% vs estimate | ₹108.97M-98.83% vs estimate |
|---|
| Q3 2025 | Feb 4, 2025 | ₹5.30+8.16% vs estimate | ₹9.43B+2.79% vs estimate |
|---|
| Q2 2025 | Nov 14, 2024 | ₹4.87+10.68% vs estimate | ₹9.57B+5.97% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹8,265.50+₹65.50 (+0.8%)
Apollo Hospitals Enterprise Limited’s quoted price sits in the upper half of its reported 52-week range, 8.9% below the high.
₹651.75+₹12.95 (+2.03%)
Manipal Health Enterprises Limited’s quoted price sits in the lower half of its reported 52-week range, 20.17% below the high.
₹854.50+₹3.35 (+0.39%)
Max Healthcare Institute Ltd’s quoted price sits in the lower half of its reported 52-week range, 28.17% below the high.
₹751.75-₹3.15 (-0.42%)
Fortis Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 28.97% below the high.
₹679.15-₹0.05 (-0.01%)
Aster DM Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 23.75% below the high.
₹1,725.20+₹10.70 (+0.62%)
Narayana Hrudayalaya Limited’s quoted price sits in the lower half of its reported 52-week range, 17.51% below the high.
₹700.95-₹1.55 (-0.22%)
Krishna Institute of Medical Sciences Limited’s quoted price sits in the lower half of its reported 52-week range, 18.27% below the high.
₹927.70+₹4.40 (+0.48%)
Yatharth Hospital & Trauma Care Services Limited’s quoted price sits in the upper half of its reported 52-week range, 21.55% below the high.